Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Varex Imaging (VREX) Research & Development (2016 - 2026)

Varex Imaging (VREX) has disclosed Research & Development for 11 consecutive years, with $21.7 million as the latest value for Q1 2026.

  • On a quarterly basis, Research & Development fell 7.66% to $21.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $89.3 million, a 0.78% decrease, with the full-year FY2025 number at $91.1 million, up 4.71% from a year prior.
  • Research & Development was $21.7 million for Q1 2026 at Varex Imaging, down from $24.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $24.2 million in Q4 2025 to a low of $18.9 million in Q2 2022.
  • A 5-year average of $21.5 million and a median of $21.8 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: rose 21.69% in 2023, then fell 7.66% in 2026.
  • Varex Imaging's Research & Development stood at $20.0 million in 2022, then increased by 2.5% to $20.5 million in 2023, then grew by 6.83% to $21.9 million in 2024, then rose by 10.5% to $24.2 million in 2025, then decreased by 10.33% to $21.7 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Research & Development are $21.7 million (Q1 2026), $24.2 million (Q4 2025), and $21.4 million (Q3 2025).